News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
QIAGEN N.V. Expects to Make Biggest Acquisition Since $1.6 Billion Digene Corporation Buy
March 15, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Qiagen NV (QIA), the Dutch company whose tools are used to predict disease and isolate DNA, may make its second-biggest acquisition to date this year.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Earnings
Biogen’s Leqembi Push Getting Easier as CEO Eyes Early-Stage Pipeline Restock
July 31, 2025
·
4 min read
·
Annalee Armstrong
MASH
Madrigal Makes Potential $2B+ Bet for CSPC’s GLP-1 Pill
July 30, 2025
·
2 min read
·
Tristan Manalac
Deals
Boehringer Links with Irish Drug Delivery Start-Up Re-Vana in $1B+ Eye Deal
July 28, 2025
·
1 min read
·
Dan Samorodnitsky
Deals
GSK Bets Up To $12B for Multi-Program Cancer Pact With Hengrui
July 28, 2025
·
2 min read
·
Tristan Manalac
